Stay updated on Mirikizumab Maintenance Study in Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Mirikizumab Maintenance Study in Ulcerative Colitis Clinical Trial page.

Latest updates to the Mirikizumab Maintenance Study in Ulcerative Colitis Clinical Trial page
- CheckyesterdayChange DetectedThe history shows a new revision (v3.5.4) dated 2026-05-13 that adds several core study sections (Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Arms and Interventions, Study Design, Study Status) and related document/contacts sections, while the previous revision (v3.5.3) dated 2025-10-14 is removed.SummaryDifference0.5%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA site revision/version indicator was updated from v3.5.2 to v3.5.3 on the record history page, reflecting a platform update rather than a change to the trial information.SummaryDifference0.0%

- Check30 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be a minor technical update to the page history.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision v3.5.0 was added to the history and Revision v3.4.3 was removed.SummaryDifference0.0%

- Check65 days agoChange DetectedThe site version was updated from v3.4.2 to v3.4.3; no other changes to page content or layout were observed.SummaryDifference0.0%

- Check94 days agoChange DetectedAdded site revision note v3.4.2. Removed the government funding lapse banner and the older v3.4.1 revision note.SummaryDifference0.3%

Stay in the know with updates to Mirikizumab Maintenance Study in Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mirikizumab Maintenance Study in Ulcerative Colitis Clinical Trial page.